Senate Republicans voted Thursday to keep the WISeR program, a Medicare prior authorization pilot that adds artificial‑intelligence‑driven checks to certain services in six states.
Vote blocks Democratic effort to end the experiment
The measure, introduced by a group of Democratic senators, sought to invoke the Congressional Review Act and terminate the pilot. The Senate rejected it 46‑50, with all Republicans supporting the program and all Democrats opposing it.
Senators Ron Wyden, Maria Cantwell, Richard Blumenthal and Kirsten Gillibrand were among those who argued the model delays care for seniors. They warned that Medicare beneficiaries in the six participating states could see recommended treatments slowed or halted by an “AI‑driven third party.”
How the WISeR model works
The Wasteful and Inappropriate Service Reduction model, launched by the Centers for Medicare & Medicaid Services’ Innovation Center, contracts private firms to apply prior authorizations to services deemed prone to overuse, such as skin‑and‑tissue substitutes and epidural steroid injections.
Related: Digital health sees surge as large funding rounds lift investment
Traditionally, Medicare does not require pre‑approval for most services. The pilot therefore represents a shift toward more intensive oversight, aiming to reduce wasteful spending and potential fraud.
Republican Senator Mike Crapo argued that the reimbursement structure of Medicare encourages high volume rather than high‑value care, and that the pilot could help curb unnecessary expenditures.
While the Senate preserved the program for now, a separate development in the House may affect its future.
For newcomers to the policy arena, it helps to see why this debate matters beyond the immediate legislative vote.
Related: CMS recalculates Medicare stars post-Clover loss, no freebie for plans
Critics of the pilot point to increased administrative burdens on clinicians, who must now manage extra steps before delivering certain treatments.
Supporters, however, contend that the program targets services with a history of overuse and that the added oversight could free resources for higher‑value interventions. They note that the pilot’s data could inform future policy decisions about where prior authorizations are most effective.
The Senate’s decision keeps the WISeR experiment in place for the remainder of its authorized period, but the upcoming House amendment suggests that the program’s funding could be curtailed. As the debate continues, both sides agree that the goal is to protect Medicare’s sustainability while ensuring beneficiaries receive appropriate care.
